Hospira Healthcare Corporation et al. v The Kennedy Institute of Rheumatology

Call to arrange a consultation

2020

39099

Pending

Biosimilars

Application for leave to appeal to the Supreme Court of Canada in a patent impeachment action relating to Patent No. 2,261,630 (infliximab)

Counsel to:

Pfizer Canada Inc.

The decision is reported

Partner

Counsel

Associate